172 related articles for article (PubMed ID: 36394717)
1. Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients.
Ten Cate C; Huijs SMH; Willemsen ACH; Pasmans RCOS; Eekers DBP; Zegers CML; Ackermans L; Beckervordersandforth J; van Raak EPM; Anten MHME; Hoeben A; Postma AA; Broen MPG
J Neurooncol; 2022 Dec; 160(3):611-618. PubMed ID: 36394717
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis.
Muglia R; Simonelli M; Pessina F; Morenghi E; Navarria P; Persico P; Lorenzi E; Dipasquale A; Grimaldi M; Scorsetti M; Santoro A; Politi LS
Eur Radiol; 2021 Jun; 31(6):4079-4086. PubMed ID: 33201284
[TBL] [Abstract][Full Text] [Related]
3. The possible relation between temporal muscle mass and glioblastoma multiforme prognosis via sarcopenia perspective.
Sütcüoğlu O; Erdal ZS; Akdoğan O; Çeltikçi E; Özdemir N; Özet A; Uçar M; Yazıcı O
Turk J Med Sci; 2023 Feb; 53(1):413-419. PubMed ID: 36945944
[TBL] [Abstract][Full Text] [Related]
4. Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials.
Furtner J; Weller M; Weber M; Gorlia T; Nabors B; Reardon DA; Tonn JC; Stupp R; Preusser M;
Clin Cancer Res; 2022 Jan; 28(1):129-136. PubMed ID: 34667022
[TBL] [Abstract][Full Text] [Related]
5. A novel radiographic marker of sarcopenia with prognostic value in glioblastoma.
Huq S; Khalafallah AM; Ruiz-Cardozo MA; Botros D; Oliveira LAP; Dux H; White T; Jimenez AE; Gujar SK; Sair HI; Pillai JJ; Mukherjee D
Clin Neurol Neurosurg; 2021 Aug; 207():106782. PubMed ID: 34186275
[TBL] [Abstract][Full Text] [Related]
6. Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma.
Lee B; Bae YJ; Jeong WJ; Kim H; Choi BS; Kim JH
Sci Rep; 2021 Oct; 11(1):19717. PubMed ID: 34611230
[TBL] [Abstract][Full Text] [Related]
7. Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.
Furtner J; Genbrugge E; Gorlia T; Bendszus M; Nowosielski M; Golfinopoulos V; Weller M; van den Bent MJ; Wick W; Preusser M
Neuro Oncol; 2019 Dec; 21(12):1587-1594. PubMed ID: 31369680
[TBL] [Abstract][Full Text] [Related]
8. Association of SARC-F Score and Rockwood Clinical Frailty Scale with CT-Derived Muscle Mass in Patients with Aortic Aneurysms.
Brown K; Cheng Y; Harley S; Allen C; Claridge M; Adam D; Lord JM; Nasr H; Juszczak M
J Nutr Health Aging; 2022; 26(8):792-798. PubMed ID: 35934824
[TBL] [Abstract][Full Text] [Related]
9. High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases.
Leitner J; Pelster S; Schöpf V; Berghoff AS; Woitek R; Asenbaum U; Nenning KH; Widhalm G; Kiesel B; Gatterbauer B; Dieckmann K; Birner P; Prayer D; Preusser M; Furtner J
PLoS One; 2018; 13(11):e0207849. PubMed ID: 30496307
[TBL] [Abstract][Full Text] [Related]
10. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia in patients with dementia: correlation of temporalis muscle thickness with appendicular muscle mass.
Cho J; Park M; Moon WJ; Han SH; Moon Y
Neurol Sci; 2022 May; 43(5):3089-3095. PubMed ID: 34846582
[TBL] [Abstract][Full Text] [Related]
12. Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study.
Broen MPG; Beckers R; Willemsen ACH; Huijs SMH; Pasmans RCOS; Eekers DBP; Ackermans L; Beckervordersandforth J; van Raak EPM; Verduin M; Anten MHME; Hoeben A; Postma AA
Neurooncol Adv; 2022; 4(1):vdac038. PubMed ID: 35475275
[TBL] [Abstract][Full Text] [Related]
13. Defining Normal Ranges of Skeletal Muscle Area and Skeletal Muscle Index in Children on CT Using an Automated Deep Learning Pipeline: Implications for Sarcopenia Diagnosis.
Somasundaram E; Castiglione JA; Brady SL; Trout AT
AJR Am J Roentgenol; 2022 Aug; 219(2):326-336. PubMed ID: 35234481
[No Abstract] [Full Text] [Related]
14. Sarcopenia and major complications in patients undergoing oncologic colon surgery.
Schneider M; Hübner M; Becce F; Koerfer J; Collinot JA; Demartines N; Hahnloser D; Grass F; Martin D
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1757-1763. PubMed ID: 34423589
[TBL] [Abstract][Full Text] [Related]
15. Quantitative muscle mass biomarkers are independent prognosis factors in primary central nervous system lymphoma: The role of L3-skeletal muscle index and temporal muscle thickness.
Leone R; Sferruzza G; Calimeri T; Steffanoni S; Conte GM; De Cobelli F; Falini A; Ferreri AJM; Anzalone N
Eur J Radiol; 2021 Oct; 143():109945. PubMed ID: 34492625
[TBL] [Abstract][Full Text] [Related]
16. Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis.
Sadhwani N; Aggarwal A; Mishra A; Garg K
Neurosurg Rev; 2022 Dec; 45(6):3619-3628. PubMed ID: 36350492
[TBL] [Abstract][Full Text] [Related]
17. Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson's Disease.
Peball M; Valent D; Grossauer A; Marini K; Ellmerer P; Wallnöfer J; Krismer F; Djamshidian A; Seppi K; Heim B
J Parkinsons Dis; 2023; 13(3):341-350. PubMed ID: 37005894
[TBL] [Abstract][Full Text] [Related]
18. Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma.
An G; Ahn S; Park JS; Jeun SS; Hong YK
J Cancer Res Clin Oncol; 2021 Mar; 147(3):901-909. PubMed ID: 32929611
[TBL] [Abstract][Full Text] [Related]
19. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
[TBL] [Abstract][Full Text] [Related]
20. Reliability and validity of measuring temporal muscle thickness as the evaluation of sarcopenia risk and the relationship with functional outcome in older patients with acute stroke.
Nozoe M; Kubo H; Kanai M; Yamamoto M; Okakita M; Suzuki H; Shimada S; Mase K
Clin Neurol Neurosurg; 2021 Feb; 201():106444. PubMed ID: 33395619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
